Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease
Internal Medicine Journal · 2024
DOI: 10.1111/imj.16563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal Medicine Journal, 2024. Verfasst von Janelle See und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Interferon-Induced Helicase, IFIH1, Autoantibodies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: NHMRC Postgraduate Scholarship, Australian Government Research Training Program Scholarship.
Abstract (Originalsprache)
To evaluate experience in a tertiary rheumatology service with melanoma differentiation‐association‐protein‐5 (MDA5) disease and testing, patients with positive autoantibody results were reviewed for the presence of clinical disease. Anti‐MDA5 positivity was detected in 2% of myositis‐specific antibody tests. Of these, 29% did not have features consistent with anti‐MDA5 disease. However, when present, MDA5 disease is severe with a high mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Monash Health, Melbourne, Victoria, Australia.
- Department of Medicine, The University of Melbourne, Melbourne, Victoria, Australia.
- Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Victoria, Australia.
- Monash Pathology, Monash Health, Melbourne, Victoria, Australia.
ORCID-Profile: Janelle See, Jessica L Fairley, Eric F Morand
Förderung
- NHMRC Postgraduate Scholarship
- Australian Government Research Training Program Scholarship
Zitieren
APA
See, J., Fairley, J. L., Yeo, A. L., Ojaimi, S., & Morand, E. F. (2024). Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. https://doi.org/10.1111/imj.16563
Vancouver
See J, Fairley JL, Yeo AL, Ojaimi S, Morand EF. Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease. Internal Medicine Journal. 2024. doi:10.1111/imj.16563
BibTeX
@article{See2024,
author = {See, Janelle and Fairley, Jessica L and Yeo, Ai L and Ojaimi, Samar and Morand, Eric F},
title = {Anti‐ MDA5 positivity: describing the frequency and spectrum of clinically evident MDA5 disease},
journal = {Internal Medicine Journal},
year = {2024},
doi = {10.1111/imj.16563}
}
EUVIMED